BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 9870871)

  • 1. Inhibition of interleukin-1alpha-induced cartilage oligomeric matrix protein degradation in bovine articular cartilage by matrix metalloproteinase inhibitors: potential role for matrix metalloproteinases in the generation of cartilage oligomeric matrix protein fragments in arthritic synovial fluid.
    Ganu V; Goldberg R; Peppard J; Rediske J; Melton R; Hu SI; Wang W; Duvander C; Heinegård D
    Arthritis Rheum; 1998 Dec; 41(12):2143-51. PubMed ID: 9870871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of monoclonal antibodies recognizing different fragments of cartilage oligomeric matrix protein in human body fluids.
    Vilim V; Lenz ME; Vytasek R; Masuda K; Pavelka K; Kuettner KE; Thonar EJ
    Arch Biochem Biophys; 1997 May; 341(1):8-16. PubMed ID: 9143347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased degradation and altered tissue distribution of cartilage oligomeric matrix protein in human rheumatoid and osteoarthritic cartilage.
    Di Cesare PE; Carlson CS; Stolerman ES; Hauser N; Tulli H; Paulsson M
    J Orthop Res; 1996 Nov; 14(6):946-55. PubMed ID: 8982138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cleavage of cartilage oligomeric matrix protein (thrombospondin-5) by matrix metalloproteinases and a disintegrin and metalloproteinase with thrombospondin motifs.
    Dickinson SC; Vankemmelbeke MN; Buttle DJ; Rosenberg K; Heinegård D; Hollander AP
    Matrix Biol; 2003 May; 22(3):267-78. PubMed ID: 12853037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase.
    Billinghurst RC; Wu W; Ionescu M; Reiner A; Dahlberg L; Chen J; van Wart H; Poole AR
    Arthritis Rheum; 2000 Mar; 43(3):664-72. PubMed ID: 10728761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of moving training on histology and biomarkers levels of articular cartilage.
    Qi C; Changlin H
    J Surg Res; 2006 Oct; 135(2):352-63. PubMed ID: 16904690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A fibronectin fragment induces type II collagen degradation by collagenase through an interleukin-1-mediated pathway.
    Yasuda T; Poole AR
    Arthritis Rheum; 2002 Jan; 46(1):138-48. PubMed ID: 11817586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro.
    Little CB; Flannery CR; Hughes CE; Mort JS; Roughley PJ; Dent C; Caterson B
    Biochem J; 1999 Nov; 344 Pt 1(Pt 1):61-8. PubMed ID: 10548534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small fragments of cartilage oligomeric matrix protein in synovial fluid and serum as markers for cartilage degradation.
    Neidhart M; Hauser N; Paulsson M; DiCesare PE; Michel BA; Häuselmann HJ
    Br J Rheumatol; 1997 Nov; 36(11):1151-60. PubMed ID: 9402858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes.
    Tetlow LC; Adlam DJ; Woolley DE
    Arthritis Rheum; 2001 Mar; 44(3):585-94. PubMed ID: 11263773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinases in mild and severe temporomandibular joint internal derangement synovial fluid.
    Srinivas R; Sorsa T; Tjäderhane L; Niemi E; Raustia A; Pernu H; Teronen O; Salo T
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 May; 91(5):517-25. PubMed ID: 11346728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of cartilage oligomeric matrix protein synthesis in human synovial cells and articular chondrocytes.
    Recklies AD; Baillargeon L; White C
    Arthritis Rheum; 1998 Jun; 41(6):997-1006. PubMed ID: 9627009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover: analyses of synovial fluid from patients with osteoarthritis.
    Ishiguro N; Ito T; Ito H; Iwata H; Jugessur H; Ionescu M; Poole AR
    Arthritis Rheum; 1999 Jan; 42(1):129-36. PubMed ID: 9920023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Esculetin (dihydroxycoumarin) inhibits the production of matrix metalloproteinases in cartilage explants, and oral administration of its prodrug, CPA-926, suppresses cartilage destruction in rabbit experimental osteoarthritis.
    Yamada H; Watanabe K; Saito T; Hayashi H; Niitani Y; Kikuchi T; Ito A; Fujikawa K; Lohmander LS
    J Rheumatol; 1999 Mar; 26(3):654-62. PubMed ID: 10090178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of oncostatin M in animal and human connective tissue collagen turnover and its localization within the rheumatoid joint.
    Cawston TE; Curry VA; Summers CA; Clark IM; Riley GP; Life PF; Spaull JR; Goldring MB; Koshy PJ; Rowan AD; Shingleton WD
    Arthritis Rheum; 1998 Oct; 41(10):1760-71. PubMed ID: 9778217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis.
    Kanyama M; Kuboki T; Kojima S; Fujisawa T; Hattori T; Takigawa M; Yamashita A
    J Orofac Pain; 2000; 14(1):20-30. PubMed ID: 11203734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
    Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
    Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1).
    Dahlberg L; Billinghurst RC; Manner P; Nelson F; Webb G; Ionescu M; Reiner A; Tanzer M; Zukor D; Chen J; van Wart HE; Poole AR
    Arthritis Rheum; 2000 Mar; 43(3):673-82. PubMed ID: 10728762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptides of type II collagen can induce the cleavage of type II collagen and aggrecan in articular cartilage.
    Yasuda T; Tchetina E; Ohsawa K; Roughley PJ; Wu W; Mousa A; Ionescu M; Pidoux I; Poole AR
    Matrix Biol; 2006 Sep; 25(7):419-29. PubMed ID: 16919430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of cartilage matrix metalloproteinases by activated protein C.
    Jackson MT; Smith MM; Smith SM; Jackson CJ; Xue M; Little CB
    Arthritis Rheum; 2009 Mar; 60(3):780-91. PubMed ID: 19248107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.